Kemira Oyj Stock Exchange Release October 22, 2014 at 8.30 am (CET+1) This is a summary of the January-September 2014 Interim report. The complete January-September 2014 Interim report with tables is attached to this release and available at www.kemira.com/investors. Third quarter: * Organic revenue growth was 3%. Reported revenue decreased 2% to EUR 541.5 million (553.7) due to impact of divestments completed earlier. * Operative EBITDA improved to EUR 69.9 million (68.9) with a margin of 12.9% (12.4%). * Reported earnings per share increased to EUR 0.16 (0.09) mainly as a result of lower non-recurring charges than in the comparable period. * On July 7, Kemira signed a preliminary agreement to acquire AkzoNobel's paper chemical business. January-September: * Organic revenue growth reached 1%. Reported revenue decreased 6% to EUR 1,589.6 million (1,683.9) due to divestments and unfavorable currency exchange rates. * Operative EBITDA decreased 3% to EUR 187.6 million (193.9) with a margin of 11.8% (11.5%). * Operative earnings per share were EUR 0.47 (0.53). * Kemira maintains its outlook for 2014. Kemira's President and CEO Jari Rosendal: "In the third quarter, Kemira's organic growth accelerated to 3% from 1% in the first half of 2014. Paper and Oil & Mining continued to grow above-the-market and Municipal & Industrial's revenue showed signs of recovery. Our operative EBITDA margin increased from 12.4% to nearly 13% with notable improvements in Oil & Mining and Municipal & Industrial. Kemira is moving forward in the next phase of its strategy implementation: focusing on growth. We updated our mid-term revenue and operative EBITDA margin targets in September, expecting revenue of EUR 2.7 billion in 2017 and an operative EBITDA margin of 15%. These targets are expected to be reached through organic growth, inorganic growth, and continuous efficiency improvements. In Paper, our market leadership position as the only global pulp and paper chemical supplier will be further strengthened by the acquisition of AkzoNobel paper chemical business, announced in July. Another positive development was the receipt of the final operating permits for our new process chemicals site in Nanjing, China. We are also increasing pulp chemical deliveries to StoraEnso's new pulp mill in Montes del Plata, Uruguay that ramps up its capacity. In Oil & Mining, we are investing in new and existing emulsion and dry polyacrylamide capacity in North America in order to harvest the good growth potential in the oil & gas market. Demand for emulsion polyacrylamide has been strong, especially in horizontal drilling and stimulation of shale oil & gas. Kemira is the second largest producer of emulsion and dry polyacrylamides in the world. In Municipal & Industrial, our new coagulant manufacturing site in Dormagen, Germany has reached its full planned capacity and in Tarragona, Spain we are currently ramping up the capacity in order to further strengthen our market leadership position in chemical raw and waste water treatment. In North America, we regained business, especially in the municipal water treatment sector and revenue decline slowed down in the third quarter. Looking ahead, we will keep our guidance for 2014 unchanged, expecting slight organic revenue growth and an operative EBITDA approximately at the same level as in 2013." KEY FIGURES AND RATIOS EUR million Jan-Dec Jul-Sep Jul-Sep Jan-Sep Jan-Sep 2013 2014 2013 2014 2013 ------------------------------------------------------------------------------ Revenue 541.5 553.7 1,589.6 1,683.9 2,229.1 ------------------------------------------------------------------------------ Operative EBITDA 69.9 68.9 187.6 193.9 251.9 ------------------------------------------------------------------------------ Operative EBITDA, % 12.9 12.4 11.8 11.5 11.3 ------------------------------------------------------------------------------ EBITDA 67.2 50.4 179.8 153.1 141.9 ------------------------------------------------------------------------------ EBITDA, % 12.4 9.1 11.3 9.1 6.4 ------------------------------------------------------------------------------ Operative EBIT 45.5 47.5 118.8 129.7 164.2 ------------------------------------------------------------------------------ Operative EBIT, % 8.4 8.6 7.5 7.7 7.4 ------------------------------------------------------------------------------ EBIT 42.9 29.0 107.2 81.5 42.6 ------------------------------------------------------------------------------ EBIT, % 7.9 5.2 6.7 4.8 1.9 ------------------------------------------------------------------------------ Share of profit or loss of associates 0.0 0.1 0.0 -1.0 -1.1 ------------------------------------------------------------------------------ Financing income and expenses -6.6 -2.4 -20.4 -31.3 -39.0 ------------------------------------------------------------------------------ Profit before tax 36.3 26.7 86.8 49.2 2.5 ------------------------------------------------------------------------------ Net profit 27.0 16.3 71.9 22.8 -25.9 ------------------------------------------------------------------------------ Earnings per share, EUR 0.16 0.09 0.44 0.12 -0.21 ------------------------------------------------------------------------------ Operative earnings per share, EUR 0.18 0.22 0.47 0.53 0.70 ------------------------------------------------------------------------------ Capital employed* 1,310.2 1,421.0 1,310.2 1,421.0 1,366.5 ------------------------------------------------------------------------------ Operative ROCE* 11.7 11.1 11.7 11.1 11.9 ------------------------------------------------------------------------------ ROCE* 5.2 2.6 5.2 2.6 3.0 ------------------------------------------------------------------------------ Capital expenditure 30.6 32.6 90.2 92.5 197.5 ------------------------------------------------------------------------------ Cash flow after investing activities 6.8 13.8 97.6 214.2 195.7 ------------------------------------------------------------------------------ Equity ratio, % at period-end 51 52 51 52 51 ------------------------------------------------------------------------------ Gearing, % at period-end 41 34 41 34 41 ------------------------------------------------------------------------------ Personnel at period-end 4,244 4,469 4,244 4,469 4,453 ------------------------------------------------------------------------------ *12-month rolling average (ROCE, % based on the reported EBIT) Definitions of key figures are available at www.kemira.com > Investors > Financial information. Comparative 2013 figures are provided in parentheses for some financial results, where appropriate. Operative EBITDA, operative EBIT, operative earnings per share and operative ROCE are excluding non-recurring items. KEMIRA'S FINANCIAL TARGETS FOR 2017 AND OUTLOOK 2014 Kemira will continue to focus on improving its profitability and reinforcing positive operative cash flow. The company will also continue to invest in order to secure future growth in the water quality and quantity management business. Kemira's financial targets have been revised in connection with its Capital Markets Day on September 9, 2014. The company's financial targets for 2017 are: * revenue EUR 2.7 billion * Operative EBITDA-% of revenue 15% * gearing level <60%. Kemira expects its capital expenditure-to-sales ratio to increase for the next few years from the current run rate of approximately 6%. In addition, Kemira expects its medium-term operative tax rate to be in the range of 22%-24%. This rate excludes non-recurring items and the contribution of income from associated companies. The basis for growth is the expanding market for chemicals related to water quality and quantity management and Kemira's strong expertise in this field. The need to increase operational efficiency in our customer industries creates opportunities for Kemira to develop new products and services for both current and new customers. Research and Development is a critical organic growth enabler for Kemira and it provides differentiation capabilities in the water quality and quantity management markets. Kemira will invest in innovation, technical expertise, and competencies in the targeted focus areas. Outlook for 2014 (unchanged) Kemira is maintaining its existing outlook for 2014. In 2014, Kemira expects its revenue in local currencies and excluding acquisitions and divestments to be slightly higher than in 2013 and its operative EBITDA to be approximately at the same level as in 2013. The guidance for 2014 is defined as follows. Kemira guidance Definition ------------------------------------------------------------------- Approximately at the same level from -5% to 5% ------------------------------------------------------------------- Slightly higher/lower from 0% to 5% or from 0% to -5% ------------------------------------------------------------------- Higher/lower from 5% to 15% or from -5% to -15% ------------------------------------------------------------------- Significantly higher/lower more than 15% or less than -15% ------------------------------------------------------------------- Helsinki, October 22, 2014 Kemira Oyj Board of Directors FINANCIAL CALENDAR 2014 AND 2015 Financial results for the year 2014 February 10, 2015 Interim Report January-March 2015 April 24, 2015 Interim Report January-June 2015 July 22, 2015 Interim Report January-September 2015 October 23, 2015 Kemira Oyj's Annual Report 2014 will be published during the week starting on February 23, 2015. The Annual General Meeting is scheduled for Monday, March 23, 2015 at 1.00 pm (CET+1). The Board of Directors of the company will convene the meeting. Press and analyst conference and conference call Kemira will arrange a press conference for analysts and the media starting at 10.30 am (8.30 am UK time) at Kemira House, Porkkalankatu 3, Helsinki. In the conference, Kemira's President and CEO Jari Rosendal and the CFO Petri Castrén will present the Q3 2014 results. The press conference will be held in English and will be webcasted at www.kemira.com/investors. Webcast will be available at www.kemira.com/investors also after the event. Presentation material will be available on Kemira's website at www.kemira.com/investors under Investors in English and at www.kemira.com/fi/sijoittajat in Finnish at about 10.00 am. Conference call in connection to the press and analyst conference You can also listen to the conference live over the phone and attend the Q&A session via a conference call. In order to participate in the call, please dial ten minutes before the conference begins: FI: +358 9 817 10465 SE: +46 85 19993555 UK: +44 20 31940550 US: +1 855 2692605 No PIN code requested. For more information, please contact Kemira Oyj Tero Huovinen, VP, Investor Relations +358 10 862 1980 Kemira is a global chemicals company serving customers in water-intensive industries. We provide expertise, application know-how and chemicals that improve our customers' water, energy and raw material efficiency. Our focus is on pulp & paper, oil & gas, mining and water treatment. In 2013, Kemira had annual revenue of EUR 2.2 billion and around 4,500 employees. Kemira shares are listed on the NASDAQ OMX Helsinki Ltd. www.kemira.com [HUG#1864541]
Kemira Oyj's Interim Report January-September 2014: Organic
Top 10 Most Recent News Articles
Dolby's Strong Quarter Meets a Flat 2027 Reality Check
A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...
Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices
Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...
Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups
Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...
Continue Reading
Linux Foundation Unveils the Global Fraud Alliance
Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...
Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial
Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...
Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation
Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...
Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027
New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...
Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games
A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...
Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts
Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...
Continue ReadingVeriSilicon's New AI/AR Glasses Tech: Game-Changer?
VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...
Continue ReadingTop 5 Most Recently Viewed Articles
S&P CoreLogic Case-Shiller Index Highlights Growth Trends
Overview of the Recent S&P CoreLogic Case-Shiller Index S&P Dow Jones Indices has released the results from its well-regarded S&P CoreLogic Case-Shiller Indices, revealing insightful trends in the U.S. housing market. The data indicates a notable 3.9% annual gain for December, reflecting a slight increase from previous figures earlier in the year. With over 27 years of...
Continue Reading
Baader Bank Enhances OTC Trading with New Extended Hours
Baader Bank Expands OTC Trading Hours MUNICH - Baader Bank AG, a prominent player in the German financial services sector, has recently announced a significant enhancement to its over-the-counter (OTC) trading hours. Starting today, clients can now engage in trading activities from 07:30 to 23:00. This extension is part of the bank's strategic initiative to bolster its...
Continue Reading
Nokia Strengthens Alliance with SoftBank Through Network Upgrade
Nokia Strengthens Alliance with SoftBank Through Network Upgrade Nokia has taken significant strides in enhancing its partnership with SoftBank Corp. through a new agreement focused on the modernization of network systems in Japan. This expansion involves the deployment of innovative 4G and 5G radio access solutions underpinned by Nokia's advanced AirScale portfolio....
Continue Reading
IS4S Launches Office to Enhance Regional Defense Solutions
IS4S Expands Operations with New Office Launch Integrated Solutions for Systems, Inc. (IS4S) has proudly announced the opening of its latest office, strategically situated to support its operations in New England. This new location enhances IS4S's capacity to engage with stakeholders associated with various Air Force programs, especially those managed by the Air Force...
Continue Reading
Discover the Future of Contract Management with CobbleStone
CobbleStone Software to Showcase Contract Management Solutions CobbleStone Software is set to exhibit its cutting-edge, AI-enhanced contract management solutions at an upcoming event, bringing together legal professionals from various sectors. This performance is part of the anticipated 2025 ACC Annual Meeting, where the company will engage with leaders in the legal...
Continue Reading